A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19

Clinical trial NCT04622332 · COMPLETED

Trial details

NCT number: NCT04622332
Sponsor: Sironax USA, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Corona Virus Infection

Start date: 2020-12-18
Primary completion: 2021-11-27
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.